Sort   by:  
 Page size 
UnknownAmyloid-β peptides in cerebrospinal fluid of patients with dementia with Lewy bodies.
Not available
S-EPMC6788069 | biostudies-literature
UnknownProdromal Dementia With Lewy Bodies: Clinical Characterization and Predictors of Progression.
Not available
S-EPMC7317511 | biostudies-literature
UnknownSex-specific associations with cerebrospinal fluid biomarkers in dementia with Lewy bodies.
Not available
S-EPMC7165383 | biostudies-literature
UnknownCharacterization of symptoms and determinants of disease burden in dementia with Lewy bodies: DEvELOP design and baseline results.
Not available
S-EPMC7908769 | biostudies-literature
UnknownContactin-1 Is Reduced in Cerebrospinal Fluid of Parkinson's Disease Patients and Is Present within Lewy Bodies.
Not available
S-EPMC7463939 | biostudies-literature
UnknownVGF Peptides in Cerebrospinal Fluid of Patients with Dementia with Lewy Bodies.
Not available
S-EPMC6801397 | biostudies-literature
UnknownGenetics Contributes to Concomitant Pathology and Clinical Presentation in Dementia with Lewy Bodies.
Not available
S-EPMC8461715 | biostudies-literature
UnknownCerebrospinal Fluid Alzheimer's Disease Biomarkers Across the Spectrum of Lewy Body Diseases: Results from a Large Multicenter Cohort.
Not available
S-EPMC5535729 | biostudies-literature
UnknownGBA and APOE ε4 associate with sporadic dementia with Lewy bodies in European genome wide association study.
Not available
S-EPMC6504850 | biostudies-literature
UnknownIdentification of novel cerebrospinal fluid biomarker candidates for dementia with Lewy bodies: a proteomic approach.
Not available
S-EPMC7301448 | biostudies-literature
Sort   by:  
 Page size